MAPT and Alzheimer disease: While cerebrospinal fluid (CSF) levels of Aβ42 and phosphorylated tau correlate with AD, these protein variant forms may not represent the best biomarkers for AD as they are also present in cognitively normal individuals and are not the relevant toxic protein species responsible for neurodegeneration in AD.